Back to search
FDAFDA · Food and drugs·Recall number D-0151-2018

Zoloft (sertraline HCl) tablets 25 mg* 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., NY, NY, 10017 NDC 0049-4960-30

Published January 10, 2018 · Recall initiated: October 20, 2017

Summary

FDA records drug Class II recall D-0151-2018, published January 10, 2018 and initiated October 20, 2017. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 1972 bottles; Lot: Lot: S84026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pfizer Inc.
Distributor
Nationwide in the USA
Lot
Lot: S84026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Zoloft (sertraline HCl) tablets 25 mg* 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., NY, NY, 10017 NDC 0049-4960-30 recalled?

Yes. FDA published recall D-0151-2018 on January 10, 2018. Reported hazard: SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent

What should I do if I have this product?

Voluntary: Firm initiated · Letter